Next Article in Journal
Calcifediol: Why, When, How Much?
Next Article in Special Issue
Synthesis and Preclinical Evaluation of Novel 68Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging
Previous Article in Journal
Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
Previous Article in Special Issue
Novel 68Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(5), 636; https://doi.org/10.3390/ph16050636
Action Date Notes Link
article xml file uploaded 22 April 2023 11:35 CEST Original file -
article xml uploaded. 22 April 2023 11:35 CEST Update https://www.mdpi.com/1424-8247/16/5/636/xml
article pdf uploaded. 22 April 2023 11:35 CEST Version of Record https://www.mdpi.com/1424-8247/16/5/636/pdf
article supplementary file uploaded. 22 April 2023 11:35 CEST - https://www.mdpi.com/1424-8247/16/5/636#supplementary
article html file updated 22 April 2023 11:37 CEST Original file https://www.mdpi.com/1424-8247/16/5/636/html
Back to TopTop